Table 1. Summary of early post-LT mortality across various studies in NASH patients vs. non-NASH patients.
| Study | Year | NASH survival (%) | Non-NASH survival (%) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Patients (N) | 30-day | 90-day | 1 year | Patients (N) | 30-day | 90-day | 1 year | |||
| Haldar et al. (10) | 2019 | 1,667 | – | – | 84.1 | 48,206 | – | – | 86.3 | |
| Agopian et al. (11) | 2012 | 144 | – | 90 | 84 | 1,150 | – | 93 | 81 | |
| Kennedy et al. (12) | 2012 | 129 | – | – | 90 | 775 | – | – | 92 | |
| Vanwagner et al.* (13) | 2012 | 115 | – | – | 81.3 | 127 | – | – | 88.1 | |
| Afzali et al.** (14) | 2011 | 1,810 | – | – | 87.6 | – | – | – | – | |
| Barritt et al. (15) | 2011 | 21 | 80.9 | – | 76.2 | 97 | 97 | – | 83.5 | |
| Charlton et al. (16) | 2011 | 1,959 | – | – | 84 | 33,971 | – | – | 87 | |
| Yalamanchili et al. (17)*** | 2010 | 18 | – | – | 85.6 | 1,795 | – | – | 86.3 | |
| Malik et al. (18) | 2009 | 98 | 95.9 | – | 78.6 | 686 | 95.8 | – | 84.8 | |
| Bhagat et al. (19) | 2009 | 71 | – | – | 82 | 83 | – | – | 92 | |
*, alcohol-induced liver disease – NASH patients more likely to die from adverse CV event; predicted by prolonged QT interval; **, authors concluded that NASH patients more likely to die from CV complications. Risk factors were old age and obesity; ***, authors concluded that NASH patients are more likely to die from CV disease.